Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Marchand

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
Plos One|January 5, 2011
Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymeraseRyan C Durk, Kamalendra Singh, Ceili A Cornelison, et al.
Journal of Hepatology|May 8, 2020
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activationJamie Bates, Archana Vijayakumar, Sarani Ghoshal, et al.
The Journal of Biological Chemistry|September 8, 2012
Biochemical mechanism of HIV-1 resistance to rilpivirineKamalendra Singh, Bruno Marchand, Devendra K Rai, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)Dmitry O Koltun, Eric Q Parkhill, Rao Kalla, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2024
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stabilityAndrew Mulato, Eric Lansdon, Ron Aoyama, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2026
Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metaboliteYili Xu, Albert Liclican, Xiaofeng Zhao, et al.
Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary FibrosisDoris T Tang, Zhimin Du, Kin S Yang, et al.
Journal of Medicinal Chemistry|July 17, 2024
Discovery of GS-7682, a Novel 4'-Cyano-Modified <i>C</i>-Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green MonkeysDustin S Siegel, Hon C Hui, Jared Pitts, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
Plos One|January 5, 2011
Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymeraseRyan C Durk, Kamalendra Singh, Ceili A Cornelison, et al.
Journal of Hepatology|May 8, 2020
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activationJamie Bates, Archana Vijayakumar, Sarani Ghoshal, et al.
The Journal of Biological Chemistry|September 8, 2012
Biochemical mechanism of HIV-1 resistance to rilpivirineKamalendra Singh, Bruno Marchand, Devendra K Rai, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)Dmitry O Koltun, Eric Q Parkhill, Rao Kalla, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2024
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stabilityAndrew Mulato, Eric Lansdon, Ron Aoyama, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2026
Identification of key metabolic enzymes involved in the activation of obeldesivir and remdesivir to the active triphosphate metaboliteYili Xu, Albert Liclican, Xiaofeng Zhao, et al.
Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary FibrosisDoris T Tang, Zhimin Du, Kin S Yang, et al.
Journal of Medicinal Chemistry|July 17, 2024
Discovery of GS-7682, a Novel 4'-Cyano-Modified <i>C</i>-Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green MonkeysDustin S Siegel, Hon C Hui, Jared Pitts, et al.
Pageof 4